Athira Pharma has been awarded a $15 million grant from the National Institute on Aging to support its phase 2 randomized, placebo-controlled ACT-AD trial (NCT04491006) investigating ATH-1017 for mild-to-moderate Alzheimer disease (AD).1  ATH-1017, a small-molecule therapeutic, promotes the activity of Hepatocyte Growth Factor (HGF) and its receptor, MET, which are expressed in the central nervous […]

Aurobindo Pharma has signed an agreement to develop and commercialise Covaxx’s Covid-19 vaccine (UB-612) for India and UNICEF. UB-612 is a synthetic peptide-based vaccine candidate and currently in the Ph-I and expected to enter Ph-II/III in early 1QCY21. Aurobindo Pharma currently has the capacity of manufacturing 220m dosages annually and augmenting the capacity to manufacture […]

Three biopharma executives discuss how a virtual JPM will impact the traditional sense of urgency around the conference, approaches to pitching, thoughts on operating at JPM post pandemic, along with some parting pearls of wisdom. This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, […]